bf/NASDAQ:GILD_icon.png

NASDAQ:GILD

Gilead Sciences, Inc.

  • Stock

$

USD

Last Close

75.82

21/09 20:00

Market Cap

93.79B

Beta: 0.41

Volume Today

4.50M

Avg: 7.33M

PE Ratio

23.29

PEG: 16.17

Dividend Yield

3.45%

Payout:79.61%

  • industry

    Drug Manufacturers / General
  • exchange

    NASDAQ Global Select
  • website

    www.gilead.com
  • ipo date

    Jan 01, 1992
  • full time employees

    14,400
  • currency

    USD

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmon...Show More

Earnings

Earnings per Share (Estimate)

0.511.522.533.52013-07-252015-07-282017-07-262019-07-302021-07-29

Revenue (Estimate)

2B4B6B8B2013-07-252015-07-282017-07-262019-07-302021-07-29

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.